Inovio Pharmaceuticals Inc (NASDAQ:INO)

4.18
BATS BZX Real-Time Price
As of 2:15pm ET
 -0.04 / -0.95%
Today’s Change
3.76
Today|||52-Week Range
9.86
+1.21%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$381.0M

Company Description

Inovio Pharmaceuticals, Inc. is a bio pharmaceutical company. It develops active DNA immunotherapies for cancer and infectious diseases. The company's portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. Its pipeline consists vgx-3100, ino-3122, ino-3106, pennvax-b and pennvax-g. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Contact Information

Inovio Pharmaceuticals, Inc.
660 West Germantown Pike
Plymouth Meeting Pennsylvania 19462-1111
P:(267) 440-4200
Investor Relations:

Employees

Shareholders

Individual stakeholders6.05%
Mutual fund holders17.48%
Other institutional14.45%

Top Executives

J. Joseph KimPresident, Chief Executive Officer & Director
Niranjan Y. SardesaiChief Operating Officer
Peter D. KiesChief Financial Officer
Jessica C. LeeVice President-Clinical Operations & Compliance
Mark L. BagarazziChief Medical Officer